NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

MICSSS: Multiplex IHC Analytical Validation (Mt Sinai)   Add to my SOP compendium

BRD ID: 3,111

Source: CIMAC-CIDC Network Tier: SOP Number of times downloaded: 73

Description

This assay analytical validation and performance report describes the methods used to validate the multiplex immunohistochemical chromogenic staining on a single slide (MICSSS) assay using sections of formalin-fixed, paraffin-embedded (FFPE) tonsil specimens. The MICSSS assay uses iterative cycles of staining, analysis, and bleaching of up to 10 markers on a single FFPE slide. The document also presents data supporting (1) the reported accuracy, precision, analytical sensitivity and specificity, and reference intervals. It is used by a Cancer Immune Monitoring and Analysis Center (CIMAC) at Mount Sinai. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/ResearchNetworks/cimacs_cidc_network.htm), a Cancer Moonshot Initiative.

Documents for Download

Analytical report_Multiplex IHC MICSSS_02192019_Mt Sinai_508_Final.pdf [Size: 2248 KB]

Biospecimens
  • Tissue - Tonsil
  • Tissue - Pancreas
  • Tissue - Colorectal
  • Tissue - Lymph Node
  • Tissue - Placenta
Diagnoses
  • Normal
  • Neoplastic - Carcinoma
  • Neoplastic - Not specified
Topics
  • Storage
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • More...